nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cover
|
|
|
2016 |
40 |
5 |
p. OFC- 1 p. |
artikel |
2 |
Introduction
|
Reddy, Uma M. |
|
2016 |
40 |
5 |
p. 271-272 2 p. |
artikel |
3 |
Masthead
|
|
|
2016 |
40 |
5 |
p. IFC- 1 p. |
artikel |
4 |
Table of Contents
|
|
|
2016 |
40 |
5 |
p. A2-A3 nvt p. |
artikel |
5 |
Topics
|
|
|
2016 |
40 |
5 |
p. A1- 1 p. |
artikel |
6 |
What we have learned about antenatal corticosteroid regimens
|
Wapner, Ronald J. |
|
2016 |
40 |
5 |
p. 291-297 7 p. |
artikel |
7 |
What we have learned about best practices for recruitment and retention in multicenter pregnancy studies
|
Salazar, Ashley |
|
2016 |
40 |
5 |
p. 321-327 7 p. |
artikel |
8 |
What we have learned about intrapartum fetal monitoring trials in the MFMU Network
|
Bloom, Steven L. |
|
2016 |
40 |
5 |
p. 307-317 11 p. |
artikel |
9 |
What we have learned about quality measures for intrapartum obstetrical care
|
Bailit, Jennifer L. |
|
2016 |
40 |
5 |
p. 318-320 3 p. |
artikel |
10 |
What we have learned about scheduling elective repeat cesarean delivery at term
|
Tita, Alan T.N. |
|
2016 |
40 |
5 |
p. 287-290 4 p. |
artikel |
11 |
What we have learned about the design of randomized trials in pregnancy
|
Thom, Elizabeth A. |
|
2016 |
40 |
5 |
p. 328-334 7 p. |
artikel |
12 |
What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth
|
Caritis, Steve N. |
|
2016 |
40 |
5 |
p. 273-280 8 p. |
artikel |
13 |
What we have learned about treating mild gestational diabetes mellitus
|
Rice, Madeline Murguia |
|
2016 |
40 |
5 |
p. 298-302 5 p. |
artikel |
14 |
What We Have Learned About Trial of Labor After Cesarean Delivery from the Maternal-Fetal Medicine Units Cesarean Registry
|
Landon, Mark B. |
|
2016 |
40 |
5 |
p. 281-286 6 p. |
artikel |
15 |
What we learned about the role of antenatal magnesium sulfate for the prevention of cerebral palsy
|
Rouse, Dwight J. |
|
2016 |
40 |
5 |
p. 303-306 4 p. |
artikel |